Skip to main content

RHUMBLINE ADVISERS

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1115418 BOSTON, MA

Position in HALO

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$25,886,550
+$3,060,462 QoQ
Shares Held
330,734
-6.4% QoQ
Ownership
0.291%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#72
of 667 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 53% Shared 0% None 47%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. HALO ranks #15 (1.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in HALO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $25,886,550 330,734
2026-03-31 $22,826,088 353,181
2025-12-31 $23,272,070 345,796
2025-09-30 $26,707,641 364,162
2025-06-30 $19,853,380 381,649
2025-03-31 $26,636,208 417,430
2024-12-31 $19,626,387 410,508
2024-09-30 $23,163,597 404,675
2024-06-30 $22,226,610 424,496
2024-03-31 $17,566,763 431,828
2023-12-31 $15,861,901 429,164
2023-09-30 $16,836,802 440,754
2023-06-30 $16,158,638 447,980
2023-03-31 $17,709,008 463,708
2022-12-31 $26,013,883 457,186
2022-09-30 $17,796,637 450,092
2022-06-30 $19,203,448 436,442
2022-03-31 $16,582,024 415,798
2021-12-31 $16,703,796 415,414
2021-09-30 $16,988,700 417,618
2021-06-30 $18,262,403 402,167
2021-03-31 $16,044,354 384,849
2020-12-31 $17,323,432 405,606
2020-09-30 $5,187,724 197,402
2020-06-30 $6,929,419 258,464
2020-03-31 $4,030,407 224,036